An Approach to the Patient With Hirsutism
January 2013
in “
Obstetrical & gynecological survey
”
New to Spironolactone? There is a guide in the encyclopedia. Read the guide → hirsutism idiopathic hirsutism androgen hyperandrogenism polycystic ovary syndrome PCOS obesity-related disorders nonclassic congenital adrenal hyperplasia CAH androgen-secreting tumors ovarian suppression antiandrogens spironolactone glucocorticoids virilizing CAH androgen suppression therapy shaving plucking waxing eflornithine androgen suppression Vaniqa
Studysummary This review discusses diagnostic and management approaches for hirsutism, emphasizing that most cases are due to polycystic ovary syndrome or obesity-related disorders, with idiopathic hirsutism often treated cosmetically. Our plain-language summary of this paper — not a Tressless recommendation.
This review outlined the diagnosis and management of hirsutism, noting that most women presenting with this condition are endocrinologically normal and can be treated cosmetically. Idiopathic hirsutism, characterized by normal androgen levels and no menstrual irregularities, is often managed with cosmetic measures like shaving, plucking, waxing, and eflornithine. Hyperandrogenism, primarily due to polycystic ovary syndrome (PCOS) and obesity-related disorders, is a common cause requiring endocrinologic evaluation. Less frequent causes include nonclassic congenital adrenal hyperplasia (CAH) and androgen-secreting tumors. Treatment strategies vary based on the underlying cause and include weight loss for obesity-related hirsutism, ovarian suppression, antiandrogens like spironolactone, and glucocorticoids for virilizing CAH. A trial of at least 6 months is recommended for androgen suppression therapy.
